Metraipolis › archive › dc_a97fa57f68e1
Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy — Europe PMC PMID:40539104
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40539104
- DOI
- 10.3389/fmicb.2025.1603671
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T22:00:17.362Z
- SHA-256 of the archived text
3ee65c3f044ad7d43d168ea308fe34c33c6cb19e9209a34ab5264934bd0f3aca- Stable URL of this page
https://metraipolis.com/documento/dc_a97fa57f68e1
How to cite
Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy — Europe PMC PMID:40539104 — Europe PMC (en), https://europepmc.org/article/MED/40539104 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a97fa57f68e1 (Metraipolis archive dc_a97fa57f68e1, sha256 3ee65c3f044ad7d43d168ea308fe34c33c6cb19e9209a34ab5264934bd0f3aca)
BibTeX
@misc{dca97fa57f68e1,
title = {Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy — Europe PMC PMID:40539104},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40539104},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a97fa57f68e1; sha256 3ee65c3f044ad7d43d168ea308fe34c33c6cb19e9209a34ab5264934bd0f3aca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40539104. Agents can read the archived copy with the MCP tool read_document.